61 results on '"Reumatologie patientenzorg"'
Search Results
2. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools
3. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis
4. Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative
5. Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: A study protocol
6. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome
7. Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis
8. The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
9. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series
10. Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients
11. Regarding “Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea”
12. Treating juvenile idiopathic arthritis to target: Recommendations of an international task force
13. Performance of the 2012 Systemic Lupus International Collaborating Clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysis
14. The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
15. Patient's experiences with the care for juvenile idiopathic arthritis across Europe
16. Tailoring Treatment in Juvenile Idiopathic Arthritis
17. Myositis is meer dan een spierziekte
18. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
19. The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
20. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
21. Juvenile idiopathic arthritis in a patient with previous diagnosis of severe congenital lupus
22. Risks and Benefits of Rituximab in the Treatment of Hashimoto Encephalopathy in Children: Two Case Reports and a Mini Review
23. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: The SHARE initiative
24. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in juvenile dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation collaborative initiative
25. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: The SHARE initiative
26. Haematopoietic stem cell transplantation for autoimmune diseases
27. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: The SHARE initiative
28. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
29. Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis
30. Relapsing/remitting type 1 diabetes
31. The development of offspring from mothers with systemic lupus erythematosus. A systematic review
32. Enhancers in autoimmune arthritis: Implications and therapeutic potential
33. The real-world decisive reasons for drug-escalation and treatment results of synthetic and biological therapy in JIA
34. Consensus-based recommendations for the management of juvenile dermatomyositis
35. Understanding inflammation in juvenile idiopathic arthritis: How immune biomarkers guide clinical strategies in the systemic onset subtype
36. The human microbiome and juvenile idiopathic arthritis
37. The Challenge of Immunoglobulin-G Subclass Deficiency and Specific Polysaccharide Antibody Deficiency--a Dutch Pediatric Cohort Study
38. Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome
39. Primary immunodeficiency associated with chromosomal aberration - an ESID survey
40. Autoinflammatory disorders in Children
41. Preparing children for blood sampling using a serious gaming app (Prik!) decreases perceived pain and distress
42. Autoimmune disease-associated gene expression is reduced by BET-inhibition
43. Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
44. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells
45. Recommendations for the management of autoinflammatory diseases
46. Targeted NGS based hereditary autoinflammatory disorder screening in routine diagnostics, two year experience in the Netherlands
47. S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH
48. Monocytes and neutrophils in the inflammatory cascade of systemic onset Juvenile Idiopathic Arthritis
49. Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa
50. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.